These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 94771

  • 1. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM.
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [Abstract] [Full Text] [Related]

  • 2. Changes in the molecular size distribution and post-transfusion survival of hydroxyethyl starch 350/0.60 as influenced by a lower degree of hydroxyethylation: a study in normal man.
    Mishler JM, Ricketts CR, Parkhouse EJ.
    J Clin Pathol; 1980 Sep; 33(9):880-4. PubMed ID: 6159372
    [Abstract] [Full Text] [Related]

  • 3. Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.
    Mishler JM, Ricketts CR, Parkhouse EJ.
    J Clin Pathol; 1980 Feb; 33(2):155-9. PubMed ID: 6154064
    [Abstract] [Full Text] [Related]

  • 4. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO, Teno RA, Gandhi JG, Newburger PE.
    Vox Sang; 1984 Feb; 47(5):325-9. PubMed ID: 6209854
    [Abstract] [Full Text] [Related]

  • 5. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
    Behne M, Thomas H, Bremerich DH, Lischke V, Asskali F, Förster H.
    Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
    [Abstract] [Full Text] [Related]

  • 6. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG, Hester JP, Vogler WR, Higby DJ, Snikeris AC, Imig KM, Greazel C, Mallard G, Burnett D, Gupta S.
    Transfusion; 1986 Apr; 26(3):258-64. PubMed ID: 2422795
    [Abstract] [Full Text] [Related]

  • 7. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG.
    Vox Sang; 1979 Apr; 37(5):268-71. PubMed ID: 93347
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM.
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM.
    J Clin Apher; 1984 Apr; 2(1):52-62. PubMed ID: 6085628
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of pentastarch in granulocyte collection by centrifugal leukapheresis.
    Lee JH, Cullis H, Leitman SF, Klein HG.
    J Clin Apher; 1995 Apr; 10(4):198-202. PubMed ID: 8770713
    [Abstract] [Full Text] [Related]

  • 11. Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.
    Mishler JM, Ricketts CR, Parkhouse EJ.
    J Clin Pathol; 1981 Apr; 34(4):361-5. PubMed ID: 6165740
    [Abstract] [Full Text] [Related]

  • 12. Alternate dosage regimens for high-molecular-weight hydroxyethyl starch.
    Rock G, McCombie N.
    Transfusion; 1985 Apr; 25(5):417-9. PubMed ID: 2413591
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Unsubstituted hydrolyzed waxy maize as a potential agent for centrifugal leukacytapheresis.
    Studebaker JF, DeBroy JA.
    Transfusion; 1984 Apr; 24(4):305-9. PubMed ID: 6205483
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of hydroxyethyl starch in normal subjects.
    Yacobi A, Stoll RG, Sum CY, Lai CM, Gupta SD, Hulse JD.
    J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
    Mishler JM, Parry ES, Sutherland BA, Bushrod JR.
    Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
    [Abstract] [Full Text] [Related]

  • 20. Alternate dosage regimens for high molecular weight hydroxyethyl starch.
    Rock G, McCombie N.
    J Clin Apher; 1985 Jun; 2(4):375-7. PubMed ID: 2415507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.